Rational Combination Immunotherapy: Understand the Biology
- 1 May 2017
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 5 (5) , 355-356
Abstract
Selecting rational treatment combinations remains a major challenge for improving immunotherapy outcomes. In this issue of Cancer Immunology Research, Zhang and colleagues reduced tumors by inhibiting CD47 in a lung carcinoma model, a treatment that inadvertently induced autophagy through inhibition of the Akt/mTOR pathway. By also targeting autophagy, the therapeutic response improved, highlighting the importance of understanding the biology beneath antitumor immunity. Cancer Immunol Res; 5(5); 355–6. ©2017 AACR. See article by Zhang et al., p. 363.Keywords
This publication has 3 references indexed in Scilit:
- Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung CancerCancer Immunology Research, 2017
- The CD47‐SIRPα signaling axis as an innate immune checkpoint in cancerImmunological Reviews, 2017
- Combination immunotherapy: a road mapJournal for ImmunoTherapy of Cancer, 2017